Pathways for Small Patient Populations with Andre Bessette

from Impact1 Voices · host Impact1 at Stanford Biodesign

Andre Bessette is the CEO of Eclipse Regenesis, a company developing a mechanical solution to short bowel syndrome. In this episode, Andre highlights the regulatory pathways available to solutions addressing needs in small patient populations. He also discusses clinical study site selection, payor engagement, and the current challenges of short bowel syndrome and necrotizing enterocolitis care.

Episode metadata supplied by the publisher feed · Published May 1, 2025

Embed this episode

Attribution link and audio player

Ready to play

Pathways for Small Patient Populations with Andre Bessette

0:00 28:53

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Impact1 Voices?

This episode is 28 minutes long.

When was this Impact1 Voices episode published?

This episode was published on May 1, 2025.

Can I download this Impact1 Voices episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!